Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited11.93706256349997.5748
Domestic EquitiesDivi's Laboratories Limited7.33721000031613.1690
Domestic EquitiesCipla Limited6.08603200000508.6080
Domestic EquitiesLupin Limited6.08582683991508.5895
Domestic EquitiesApollo Hospitals Enterprise Limited5.9080648795493.7330
Domestic EquitiesDr. Reddy's Laboratories Limited5.90483916074493.4645
Domestic EquitiesMedPlus Health Services Limited3.65443627277305.3986
Domestic EquitiesVijaya Diagnostic Centre Limited3.48112886684290.9200
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited3.0433913226254.3334
Domestic EquitiesGland Pharma Limited2.95731320549247.1407
Domestic EquitiesAjanta Pharma Limited2.8441959323237.6819
Domestic EquitiesThyrocare Technologies Limited2.62511733833219.3819
Domestic EquitiesAbbott India Limited2.587068677216.1952
Domestic EquitiesSai Life Sciences Limited2.52212555745210.7723
Domestic EquitiesDr. Lal Path Labs Limited2.4117609112201.5491
Domestic EquitiesZydus Lifesciences Limited2.34862000632196.2720
Domestic EquitiesMankind Pharma Limited2.2401757496187.2076
Domestic EquitiesNarayana Hrudayalaya Limited2.15991029215180.5037
Domestic EquitiesAurobindo Pharma Limited2.09421702630175.0133
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.0626999649172.3695
Domestic EquitiesAlkem Laboratories Limited2.0541323678171.6626
Domestic EquitiesPfizer Limited1.9635318249164.0892
Domestic EquitiesBiocon Limited1.76174226436147.2279
Domestic EquitiesSanofi India Limited1.4174230272118.4519
Domestic EquitiesSuraksha Diagnostic Limited1.39083896349116.2281
Domestic EquitiesSanofi Consumer Healthcare India Limited1.3257213659110.7907
Domestic EquitiesIPCA Laboratories Limited1.3011785412108.7324
Domestic EquitiesTorrent Pharmaceuticals Limited1.2922303364107.9915
Domestic EquitiesFortis Healthcare Limited1.20401103889100.6195
Domestic EquitiesAnthem Biosciences Limited1.0361105850386.5908
Domestic EquitiesSyngene International Limited0.9590128049280.1460
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8236151526468.8309
Domestic EquitiesEmcure Pharmaceuticals Limited0.784147027265.5277
Domestic EquitiesAstraZeneca Pharma India Limited0.63346256852.9357
Domestic EquitiesIndoco Remedies Limited0.5854183492448.9191
Domestic EquitiesOrchid Pharma Limited0.432849272736.1686
Domestic EquitiesConcord Biotech Limited0.224911173818.7910
Total 99.4801 8313.5816
Cash & Cash Equivalents and Net AssetsTriparty Repo0.4120 34.4301
Cash & Cash Equivalents and Net AssetsNet Current Assets0.1074 8.9748
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0005 0.0445
Total 0.5199 43.4494
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.